Paratek Pharmaceuticals

Opexa Therapeutics is a biotechnology company that specializes in the development of patient-specific cellular therapies for the treatment of autoimmune diseases, such as multiple sclerosis and diabetes. It offers Tovaxin, which is a vaccine for early relapsing multiple sclerosis. The company also offers an adult stem cell program that enables the production of multipotent cells generated from patients white blood cells and provides means to differentiate these stem cells into other tissue types. Opexa Therapeutics offers solutions that minimize the threat of treatment rejection. It operates clinical advisory boards for multiple sclerosis and diabetes that take care of the supervision of related procedures. The company provides products to target individual s disease progression and modification.

Ironwood Pharmaceuticals, based in Boston, MA, is a prominent healthcare company dedicated to advancing the treatment of gastrointestinal (GI) diseases and enhancing the standard of care for GI patients. With a focus on innovation, Ironwood aims to address the needs of the millions of Americans affected by GI disorders, thereby reducing hospital visits and healthcare costs associated with these conditions. Through their deep understanding of the unique GI patient journey, Ironwood Pharmaceuticals is committed to delivering meaningful solutions that improve patient outcomes and quality of life. The company's culture emphasizes collaboration and innovation, ensuring that their team members work together to make a significant difference in the lives of those suffering from gastrointestinal diseases. Generated from the website

Paratek Pharmaceuticals is a privately held biopharmaceutical company, which is engaged in the discovery and commercialization of new therapeutics that treat life-threatening infectious and other serious diseases. The company s mission at its founding was to overcome the major worldwide problem of bacterial resistance through the application of its proprietary technologies. Paratek was founded in 1996 by Dr. Stuart B. Levy, professor at Tufts University School of Medicine, and by Dr. Walter Gilbert, a Nobel Prize-winning professor emeritus at Harvard University. The company utilizes two scientific platforms to develop multiple products to combat, cure and prevent infectious and other serious diseases. Paratek Pharmaceuticals is headquartered in Boston.